SEC Form 4 · accession 0001654954-18-010713
CorMedix Inc. · CRMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Steven W Lefkowitz
Director
Period of report
Oct 1, 2018
Accepted (ET)
Oct 1, 2018 · 4:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.001 par value per shareF1 | holding | — | — | — | 195,379 | D | ||
| Common Stock, $0.001 par value per shareF2 | holding | — | — | — | 115,757 | I | Wade Capital Corporation Money Purchase Plan | |
| Common Stock, $0.001 par value per share | holding | — | — | — | 10,000 | I | Reporting Person's Wife |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF3 | $0.00 | Oct 1, 2018 | A | 10,000 | A | — | — | Common Stock | 10,000 | 10,000 | D |
| Stock Option (Right to Buy Common Stock)F4 | $0.57 | holding | — | — | — | — | Feb 16, 2028 | Common Stock | 40,000 | 40,000 | D |
| Restricted Stock UnitsF5 | — | holding | — | — | — | — | — | Common Stock | 10,000 | 10,000 | D |
| Restricted Stock UnitsF5 | — | holding | — | — | — | — | — | Common Stock | 6,000 | 6,000 | D |
| Stock Option (Right to Buy Common Stock)F6 | $0.45 | holding | — | — | — | — | Jun 25, 2027 | Common Stock | 75,000 | 75,000 | D |
| Warrant (Right to Purchase Common Stock) | $0.90 | holding | — | — | — | Jan 8, 2015 | Jan 8, 2020 | Common Stock | 22,500 | 22,500 | D |
| Warrant (Right to Purchase Common Stock) | $0.90 | holding | — | — | — | Jan 8, 2015 | Jan 8, 2020 | Common Stock | 15,000 | 15,000 | D |
Explanation of responses
- F1Includes 24,963 shares held by the reporting person for the benefit of his minor son.
- F2The reporting person beneficially owns these securities through Wade Capital Corporation Money Purchase Plan (an entity for which he has voting and investment control).
- F3These restricted stock units were granted on 10/01/2018 for service on the Company's Strategic Finance Committee. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest monthly and will vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F4These options vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F5These Restricted Stock Units were granted on 2/16/2018. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. The restricted stock units vest in full on the first anniversary of the date of grant, subject to continued service on the board.
- F6These options were granted on 6/25/2017. These options vest 1/3 on the date of grant, 1/3 on the first anniversary of the date of grant and 1/3 on the second anniversary of the date of grant.